References

Fat infiltration in skeletal muscle: Influential triggers and regulatory mechanism

10.1016/j.isci.2024.109221 · 2024 · External reference

Epidemiology of myosteatosis

10.1097/mco.0b013e328337d826 · 2010 · External reference

Impaired skeletal muscle regeneration in diabetes: From cellular and molecular mechanisms to novel treatments

10.1016/j.cmet.2024.02.014 · 2024 · External reference

Association between myosteatosis and impaired glucose metabolism: A deep learning whole-body magnetic resonance imaging population phenotyping approach

10.1002/jcsm.13527 · 2024 · External reference

Repetitive intermittent hyperglycemia drives the M1 polarization and inflammatory responses in THP-1 macrophages through the mechanism involving the TLR4-IRF5 pathway

10.3390/cells9081892 · 2020 · External reference

Mechanisms of insulin resistance in type 1 diabetes mellitus: A case of glucolipotoxicity in skeletal muscle

10.1002/jcp.31419 · 2024 · External reference

Effects of type 1 diabetes mellitus on skeletal muscle: Clinical observations and physiological mechanisms

10.1111/j.1399-5448.2010.00699.x · 2011 · External reference

Energy metabolism and frailty: The potential role of exercise-induced myokines - A narrative review

10.1016/j.arr.2022.101780 · 2022 · External reference

10.1002/cphy.c190029 · 2020 · Admitted local publication

Unraveling skeletal muscle insulin resistance: Molecular mechanisms and the restorative role of exercise

10.1161/circresaha.125.325532 · 2025 · External reference

Metabolism of tissue macrophages in homeostasis and pathology

10.1038/s41423-021-00791-9 · 2022 · External reference

The peripheral peril: Injected insulin induces insulin insensitivity in type 1 diabetes

10.2337/dbi19-0026 · 2020 · External reference

Acute hyperglycaemia induces an inflammatory response in young patients with type 1 diabetes

10.1080/07853890802126547 · 2008 · External reference

Inflammatory markers are increased in youth with type 1 diabetes: The SEARCH Case-Control study

10.1210/jc.2009-1993 · 2010 · External reference

Inflammation and lipid signaling in the etiology of insulin resistance

10.1016/j.cmet.2012.04.001 · 2012 · External reference

Mitochondrial (Dys)function and insulin resistance: From pathophysiological molecular mechanisms to the impact of diet

10.3389/fphys.2019.00532 · 2019 · External reference

Muscle mitochondrial function is impaired in adults with type 1 diabetes

10.1016/j.jdiacomp.2024.108798 · 2024 · External reference

Considering type 1 diabetes as a form of accelerated muscle aging

10.1249/jes.0000000000000184 · 2019 · External reference

Altered energetic properties in skeletal muscle of men with well-controlled insulin-dependent (type 1) diabetes

10.1152/ajpendo.00343.2002 · 2003 · External reference

Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes

10.2337/diabetes.53.6.1412 · 2004 · External reference

Altered mitochondrial bioenergetics and ultrastructure in the skeletal muscle of young adults with type 1 diabetes

10.1007/s00125-018-4602-6 · 2018 · External reference

A ceramide-centric view of insulin resistance

10.1016/j.cmet.2012.04.002 · 2012 · External reference

Mitochondrial dysfunction: Roles in skeletal muscle atrophy

10.1186/s12967-023-04369-z · 2023 · External reference

TNF-alpha impairs regulation of muscle oxidative phenotype: Implications for cachexia

10.1096/fj.09-150714 · 2010 · External reference

The peroxisome proliferator-activated receptor γ coactivator 1α/β (PGC-1) coactivators repress the transcriptional activity of NF-κB in skeletal muscle cells

10.1074/jbc.m112.375253 · 2013 · External reference

The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)

10.1074/jbc.275.12.9047 · 2000 · External reference

Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes

10.2337/diabetes.51.10.2944 · 2002 · External reference

Skeletal muscle mitochondria in insulin resistance: Differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility

10.1210/jc.2010-0822 · 2011 · External reference

Mitochondrial damage-associated molecular patterns: A new insight into metabolic inflammation in type 2 diabetes mellitus

10.1002/dmrr.3733 · 2024 · External reference

Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis

10.1016/j.immuni.2012.01.009 · 2012 · External reference

Rel A/p65 is required for cytokine-induced myotube atrophy

10.1152/ajpcell.00111.2012 · 2012 · External reference

Mitochondria and cell death-associated inflammation

10.1038/s41418-022-01094-w · 2023 · External reference

Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: The role of protein kinase C and NAD(P)H-oxidase activation

10.2337/diabetes.52.11.2795 · 2003 · External reference

Delayed skeletal muscle mitochondrial ADP recovery in youth with type 1 diabetes relates to muscle insulin resistance

10.2337/db14-0765 · 2015 · External reference

Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes

10.1111/j.1365-2796.2010.02298.x · 2011 · External reference

Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance

10.1016/j.cmet.2007.10.013 · 2008 · External reference

Liver and muscle contribute differently to the plasma acylcarnitine pool during fasting and exercise in humans

10.1210/jc.2016-1859 · 2016 · External reference

Muscle-specific relation of acetylcarnitine and intramyocellular lipids to chronic hyperglycemia: A pilot 3-T

10.1002/oby.22846 · 2020 · External reference

Skeletal muscle lipid content and insulin resistance: Evidence for a paradox in endurance-trained athletes

10.1210/jc.86.12.5755 · 2001 · External reference

Endurance training modulates intramyocellular lipid compartmentalization and morphology in skeletal muscle of lean and obese women

10.1210/jc.2013-2044 · 2013 · External reference

Intracellular localization of diacylglycerols and sphingolipids influences insulin sensitivity and mitochondrial function in human skeletal muscle

10.1172/jci.insight.96805 · 2018 · External reference

Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide

10.1007/s00125-011-2065-0 · 2011 · External reference

Adipocyte ceramides-the nexus of inflammation and metabolic disease

10.3389/fimmu.2020.576347 · 2020 · External reference

CerS6-derived sphingolipids interact with Mff and promote mitochondrial fragmentation in obesity

10.1016/j.cell.2019.05.008 · 2019 · External reference

Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade

10.2337/diabetes.48.6.1270 · 1999 · External reference

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance

10.1038/nm.2279 · 2011 · External reference

AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation

10.1016/j.biopha.2021.112563 · 2022 · External reference

AMPK, insulin resistance, and the metabolic syndrome

10.1172/jci67227 · 2013 · External reference

Exercise, GLUT4, and skeletal muscle glucose uptake

10.1152/physrev.00038.2012 · 2013 · External reference

TOR-centric view on insulin resistance and diabetic complications: Perspective for endocrinologists and gerontologists

10.1038/cddis.2013.506 · 2013 · External reference

Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability

10.1096/fj.03-0269fje · 2003 · External reference

Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men

10.2337/db07-1318 · 2008 · External reference

Regulation of muscle fiber type and running endurance by PPARdelta

10.1371/journal.pbio.0020294 · 2004 · External reference

mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex

10.1038/nature06322 · 2007 · External reference

Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones

10.1172/jci31561 · 2007 · External reference

Dysregulation of the TNF-α-OTUD3-PPARγ signaling axis exacerbates retinal oxidative stress and inflammation in diabetic retinopathy

10.1016/j.lfs.2025.123933 · 2025 · External reference

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

10.1126/science.271.5249.665 · 1996 · External reference

Ceramides - lipotoxic inducers of metabolic disorders

10.1016/j.tem.2015.07.006 · 2015 · External reference

Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance

10.2337/db12-0686 · 2013 · External reference

Vascular complications in diabetes mellitus: the role of endothelial dysfunction

10.1042/cs20050025 · 2005 · External reference

Muscle and serum myostatin expression in type 1 diabetes

10.14814/phy2.14500 · 2020 · External reference

Early diabetic nephropathy in type 1 diabetes: new insights

10.2337/dc13-0631 · 2014 · External reference

Muscle-organ crosstalk: the emerging roles of myokines

10.1210/endrev/bnaa016 · 2020 · External reference

Exercise-induced changes in visceral adipose tissue mass are regulated by IL-6 signaling: A randomized controlled trial

10.1530/ey.16.11.9 · 2019 · External reference

Dual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscle

10.2337/db07-1062 · 2008 · External reference

Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients

10.2337/diabetes.53.9.2232 · 2004 · External reference

Crosstalk of reactive oxygen species and NF-κB signaling

10.1007/978-3-540-68706-1_1391 · 2011 · External reference

Ceramide kinase regulates TNF-α-induced immune responses in human monocytic cells

10.1038/s41598-021-87795-7 · 2021 · External reference

IL-15 mediates mitochondrial activity through a PPAR

10.1155/2016/5465804 · 2016 · External reference

Biological aspects of selected myokines in skeletal muscle: focus on aging

10.3390/ijms22168520 · 2021 · External reference

Interleukin-15 increases glucose uptake in skeletal muscle. An antidiabetogenic effect of the cytokine

10.1016/j.bbagen.2006.09.001 · 2006 · External reference

IL-15 improves skeletal muscle oxidative metabolism and glucose uptake in association with increased respiratory chain supercomplex formation and AMPK pathway activation

10.1016/j.bbagen.2018.10.021 · 2019 · External reference

Interleukin-15 facilitates muscle regeneration through modulation of fibro/adipogenic progenitors

10.1186/s12964-018-0251-0 · 2018 · External reference

Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size

10.1152/ajpcell.00105.2009 · 2009 · External reference

The effects of myostatin on adipogenic differentiation of human bone marrow-derived mesenchymal stem cells are mediated through cross-communication between Smad3 and Wnt/beta-catenin signaling pathways

10.1074/jbc.m708968200 · 2008 · External reference

Myostatin and its regulation: A comprehensive review of myostatin inhibiting strategies

10.3389/fphys.2022.876078 · 2022 · External reference

Myostatin inhibition therapy for insulin-deficient type 1 diabetes

10.1038/srep32495 · 2016 · External reference

Progress and challenges in the biology of FNDC5 and irisin

10.1210/endrev/bnab003 · 2021 · External reference

Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies

10.1113/jphysiol.2013.264655 · 2014 · External reference

Associations of circulating irisin with FNDC5 expression in fat and muscle in type 1 and type 2 diabetic mice

10.3390/biom11020322 · 2021 · External reference

A case-control study to evaluate irisin levels in patients with type 1 diabetes mellitus

10.1007/s11845-024-03626-4 · 2024 · External reference

Muscles, exercise and obesity: skeletal muscle as a secretory organ

10.1038/nrendo.2012.49 · 2012 · External reference

Inter-organ steroid hormone signaling promotes myoblast fusion via direct transcriptional regulation of a single key effector gene

10.1016/j.cub.2024.02.056 · 2024 · External reference

Expression of anti-inflammatory macrophage genes within skeletal muscle correlates with insulin sensitivity in human obesity and type 2 diabetes

10.1007/s00125-013-2897-x · 2013 · External reference

Powerful signals for weak muscles

10.1016/j.arr.2009.02.001 · 2009 · External reference

The effects of obesity on skeletal muscle regeneration

10.3389/fphys.2013.00371 · 2013 · External reference

Macrophages, immunity, and metabolic disease

10.1016/j.immuni.2014.05.010 · 2014 · External reference

The role of metabolic remodeling in macrophage polarization and its effect on skeletal muscle regeneration

10.1089/ars.2017.7420 · 2019 · External reference

Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle

10.1038/ncb2014 · 2010 · External reference

Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis

10.1038/ncb2015 · 2010 · External reference

Denervation-activated STAT3-IL-6 signalling in fibro-adipogenic progenitors promotes myofibres atrophy and fibrosis

10.1038/s41556-018-0151-y · 2018 · External reference

Skeletal muscle atrophy and increased intramuscular fat after incomplete spinal cord injury

10.1038/sj.sc.3101968 · 2007 · External reference

Diabetic neuropathy: A position statement by the american diabetes association

10.2337/dc16-2042 · 2017 · External reference

Risk factors for diabetic peripheral neuropathy and cardiovascular autonomic neuropathy in the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study

10.2337/db19-1046 · 2020 · External reference

Length dependent loss of motor axons and altered motor unit properties in human diabetic polyneuropathy

10.1016/j.clinph.2013.09.037 · 2014 · External reference

Skeletal muscle morphology and contractile function in relation to muscle denervation in diabetic neuropathy

10.1152/japplphysiol.01139.2013 · 2014 · External reference

Motor dysfunction in diabetes

10.1002/dmrr.2257 · 2012 · External reference

Isokinetic muscle strength in long-term IDDM patients in relation to diabetic complications

10.2337/diabetes.45.4.440 · 1996 · External reference

Muscular atrophy in diabetic neuropathy: a stereological magnetic resonance imaging study

10.1007/s001250050788 · 1997 · External reference

Atrophy of foot muscles: a measure of diabetic neuropathy

10.2337/diacare.27.10.2382 · 2004 · External reference

Accelerated atrophy of lower leg and foot muscles--a follow-up study of long-term diabetic polyneuropathy using magnetic resonance imaging (MRI)

10.1007/s00125-009-1372-1 · 2009 · External reference

MRI of skeletal muscles in participants with type 2 diabetes with or without diabetic polyneuropathy

10.1148/radiol.2020192647 · 2020 · External reference

Excessive adipose tissue infiltration in skeletal muscle in individuals with obesity, diabetes mellitus, and peripheral neuropathy: association with performance and function

10.2522/ptj.20080079 · 2008 · External reference

Reduced lower-limb muscle strength and volume in patients with type 2 diabetes in relation to neuropathy, intramuscular fat, and vitamin D levels

10.2337/dc15-0995 · 2016 · External reference

Follistatin and follistatin-like 3 in metabolic disorders

10.1016/j.prostaglandins.2023.106785 · 2023 · External reference

Hyperglycemia suppresses lactate clearance during exercise in type 1 diabetes

10.1210/clinem/dgae005 · 2024 · External reference

Hyperketonemia (ketosis), oxidative stress and type 1 diabetes

10.1016/j.pathophys.2006.05.005 · 2006 · External reference

Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients

10.2337/diabetes.48.9.1850 · 1999 · External reference

Sphingolipid metabolism and signaling in skeletal muscle: From physiology to physiopathology

10.3389/fendo.2020.00491 · 2020 · External reference

Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance

10.2337/db08-1228 · 2009 · External reference

Ceramides as risk markers for future cardiovascular events and all-cause mortality in long-standing type 1 diabetes

10.2337/db23-0052 · 2023 · External reference

4-Hydroxy-2-nonenal, a lipid peroxidation product, as a biomarker in diabetes and its complications: challenges and opportunities

10.1080/10715762.2020.1866756 · 2021 · External reference

Circulating cell-free mitochondrial DNA in diabetes mellitus: Current insights and unexplored frontiers

10.1111/jdi.70071 · 2025 · External reference

Mitochondrial DNA in extracellular vesicles declines with age

10.1111/acel.13283 · 2021 · External reference

Sirtuins and NAD

10.1161/circresaha.118.312498 · 2018 · External reference

Impaired nicotinamide adenine dinucleotide (NAD

10.1111/jdi.13303 · 2020 · External reference

Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans

10.1093/ajcn/nqaa072 · 2020 · External reference

Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study

10.1007/s001250051123 · 1999 · External reference

Intramyocellular lipids and insulin resistance

10.1111/j.1462-8902.2004.00339.x · 2004 · External reference

Magnetic resonance quantification of skeletal muscle lipid infiltration in a humanized mouse model of Duchenne muscular dystrophy

10.1002/nbm.4869 · 2023 · External reference

Single-cell RNA sequencing and lipidomics reveal cell and lipid dynamics of fat infiltration in skeletal muscle

10.1002/jcsm.12643 · 2021 · External reference

Myosteatosis: Diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver disease

10.1016/j.jhepr.2023.100963 · 2024 · External reference

Sprint training increases muscle oxidative metabolism during high-intensity exercise in patients with type 1 diabetes

10.2337/dc08-0329 · 2008 · External reference

Effects of HIIT interventions on cardiorespiratory fitness and glycemic parameters in adults with type 1 diabetes: A systematic review and meta-analysis

10.1007/s40279-024-02059-4 · 2024 · External reference

Physical activity/exercise and diabetes: A position statement of the American Diabetes Association

10.2337/dc16-1728 · 2016 · External reference

High-intensity interval training, caloric restriction, or their combination have beneficial effects on metabolically acquired peripheral neuropathy

10.2337/figshare.26764066 · 2024 · External reference

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: Position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA)

10.1007/s00125-020-05263-9 · 2020 · External reference

Exercise in adults with type 1 diabetes mellitus

10.1007/978-3-032-05988-8_270 · 2023 · External reference

A comparison of substrate utilization profiles during maximal and submaximal exercise tests in athletes

10.3389/fpsyg.2022.854451 · 2022 · External reference

The effect of oral leucine on protein metabolism in adolescents with type 1 diabetes mellitus

10.1186/1687-9856-2010-493258 · 2010 · External reference

Investigating the neuroprotective effect of oral omega-3 fatty acid supplementation in type 1 diabetes (nPROOFS1): A randomized placebo-controlled trial

10.2337/db21-0136 · 2021 · External reference

Effects of omega-3 supplementation on endothelial function, vascular structure, and metabolic parameters in adolescents with type 1 diabetes mellitus: A randomized clinical trial

10.3389/fnut.2022.962773 · 2022 · External reference

Exploring the causal effect of omega-3 polyunsaturated fatty acid levels on the risk of type 1 diabetes: A Mendelian randomization study

10.3389/fgene.2024.1353081 · 2024 · External reference

The role of vitamin D supplementation in type 1, type 2, and gestational diabetes: A comprehensive updated narrative review

10.3390/clinpract15080148 · 2025 · External reference

Does creatine supplementation improve glycemic control and insulin resistance in healthy and diabetic patients? A systematic review and meta-analysis

10.1016/j.clnesp.2021.11.006 · 2022 · External reference

The interplay of mitochondrial dysfunction in oral diseases: Recent updates in pathogenesis and therapeutic implications

10.1016/j.mito.2024.101942 · 2024 · External reference

MitoQ supplementation augments acute exercise-induced increases in muscle PGC1α mRNA and improves training-induced increases in peak power independent of mitochondrial content and function in untrained middle-aged men

10.1016/j.redox.2022.102341 · 2022 · External reference

Chronic supplementation with a mitochondrial antioxidant (MitoQ) improves vascular function in healthy older adults

10.1161/hypertensionaha.117.10787 · 2018 · External reference

Chronic oral ingestion of L-carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humans

10.1113/jphysiol.2010.201343 · 2011 · External reference

Effect of bimagrumab vs placebo on body fat mass among adults with type 2 diabetes and obesity: A phase 2 randomized clinical trial

10.1001/jamanetworkopen.2020.33457 · 2021 · External reference

Activation of skeletal muscle AMPK promotes glucose disposal and glucose lowering in non-human primates and mice

10.1016/j.cmet.2017.04.010 · 2017 · External reference

Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans

10.1016/j.cmet.2011.10.002 · 2011 · External reference

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients

10.1017/s0007114511000316 · 2011 · External reference

AMPK and PPARdelta agonists are exercise mimetics

10.1016/j.cell.2008.09.014 · 2008 · External reference

PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

10.1038/83336 · 2001 · External reference